• SPX
  • $5,948.71
  • 0.53 %
  • $31.60
  • DJI
  • $43,870.35
  • 1.06 %
  • $461.88
  • N225
  • $38,283.85
  • 0.68 %
  • $257.68
  • FTSE
  • $8,201.24
  • 0.64 %
  • $51.97
  • IXIC
  • $18,972.42
  • 0.03 %
  • $6.28
Better Therapeutics, Inc. (BTTX) Stock Price, News & Analysis

Better Therapeutics, Inc. (BTTX) Stock Price, News & Analysis

Currency in USD Disclaimer

$0.00

-$0

(0%)

Day's range
$0
Day's range
$0
50-day range
$1.0E-6
Day's range
$0.001
  • Country: US
  • ISIN: US08773T1043
52 wk range
$0
Day's range
$0.27


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -27.28
  • Piotroski Score 2.00
  • Grade Buy
  • Symbol (BTTX)
  • Company Better Therapeutics, Inc.
  • Price $0.00
  • Changes Percentage (0%)
  • Change -$0
  • Day Low $0.00
  • Day High $0.00
  • Year High $0.27

Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in the United States. Its lead product candidate in development is BT-001, an investigational PDT platform that uses digitally delivered Nutritional Cognitive Behavioral Therapy to treat type 2 diabetes. The company's products under development also include BT-002, a PDT that help patients with hypertension improve their blood pressure; and BT-003, a PDT that help patients with hyperlipidemia enhance cholesterol levels. Better Therapeutics, Inc. was founded in 2015 and is headquartered in San Francisco, California.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 12/09/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$1.10
  • Trailing P/E Ratio -0.01
  • Forward P/E Ratio -0.01
  • P/E Growth -0.01
  • Net Income $-39,760,000

Income Statement

Quarterly

Annual

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Better Therapeutics, Inc. Frequently Asked Questions

  • What were the earnings of BTTX in the last quarter?

    In the last quarter Better Therapeutics, Inc. earnings were on Thursday, November, 9th. The Better Therapeutics, Inc. maker reported -$0.15 EPS for the quarter, beating analysts' consensus estimates of -$0.19 by $0.04.

  • What is the Better Therapeutics, Inc. stock price today?

    Today's price of Better Therapeutics, Inc. is $0.00 — it has decreased by 0% in the past 24 hours. Watch Better Therapeutics, Inc. stock price performance more closely on the chart.

  • Does Better Therapeutics, Inc. release reports?

    Yes, you can track Better Therapeutics, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Better Therapeutics, Inc. stock forecast?

    Watch the Better Therapeutics, Inc. chart and read a more detailed Better Therapeutics, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Better Therapeutics, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Better Therapeutics, Inc. stock ticker.

  • How to buy Better Therapeutics, Inc. stocks?

    Like other stocks, BTTX shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Better Therapeutics, Inc.'s EBITDA?

    Better Therapeutics, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Better Therapeutics, Inc.’s financial statements.

  • What is the Better Therapeutics, Inc.'s net income ratio for the financial year 2022?

    The net income ratio for the financial year 2022 is 0, which equates to approximately 0.00%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Better Therapeutics, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Better Therapeutics, Inc.'s financials relevant news, and technical analysis. Better Therapeutics, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Better Therapeutics, Inc. stock currently indicates a “sell” signal. For more insights, review Better Therapeutics, Inc.’s technical analysis.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.